SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-150190
Filing Date
2013-04-11
Accepted
2013-04-11 06:26:17
Documents
6
Period of Report
2013-05-21
Effectiveness Date
2013-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d517085ddef14a.htm DEF 14A 1500447
2 GRAPHIC g517085g25b38.jpg GRAPHIC 8622
3 GRAPHIC g517085g28e77.jpg GRAPHIC 7286
4 GRAPHIC g517085g41k63.jpg GRAPHIC 7790
5 GRAPHIC g517085g45x09.jpg GRAPHIC 12263
6 GRAPHIC g517085g86s53.jpg GRAPHIC 59929
  Complete submission text file 0001193125-13-150190.txt   1634566
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 13754963
SIC: 2834 Pharmaceutical Preparations